about
Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cellsHigh baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.Serum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report.Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review.Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.A Single Zidovudine (AZT) Administration Delays Hepatic Cell Proliferation by Altering Oxidative State in the Regenerating Rat Liver.The proliferation marker thymidine kinase 1 in clinical useSerum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.
P2860
Q31154269-E87EEA90-F022-4799-9BC0-D874FF766380Q33838195-8FDD6FDB-8153-4213-ABDE-039E7C296D6EQ34248556-F84435EF-F478-4E62-8E6B-6593E14E2172Q34467060-E85A3593-510D-41C2-A156-E08A8594B7ABQ34473056-2F5D2587-C171-4685-A003-D9085FC43520Q34732928-842014F9-B697-4AEF-A6BA-1BE8E910AAC7Q35944455-2845F02F-E51A-4F05-BC95-BCF4A052688CQ38775709-D833D8B0-806E-4F9B-963A-4F012D9C7AC5Q40839398-574872ED-5BD6-4BEF-B1FA-A8AB4700021FQ41919532-D79A37B2-813F-478C-A341-652B1C954A69Q42141365-E2837B81-0338-4D5D-823A-A04300C44450Q42409044-03A1C6F5-6154-4DE3-8E35-E0671CA23A6EQ45348344-4AEDD0F2-AB72-4431-96FD-17E582F9F52DQ48367546-CC0CD819-2A50-4050-A7B8-66E8B92D4B38Q54124261-406E93D1-3024-4351-90CC-3429BF31A39E
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Thymidine kinase and cancer monitoring.
@ast
Thymidine kinase and cancer monitoring.
@en
Thymidine kinase and cancer monitoring.
@nl
type
label
Thymidine kinase and cancer monitoring.
@ast
Thymidine kinase and cancer monitoring.
@en
Thymidine kinase and cancer monitoring.
@nl
prefLabel
Thymidine kinase and cancer monitoring.
@ast
Thymidine kinase and cancer monitoring.
@en
Thymidine kinase and cancer monitoring.
@nl
P2093
P1433
P1476
Thymidine kinase and cancer monitoring
@en
P2093
Arnulf Stenzl
Christian Schwentner
Georgios Gakis
Joerg Hennenlotter
Stefan Aufderklamm
Tilman Todenhöfer
P356
10.1016/J.CANLET.2011.10.025
P407
P577
2011-11-06T00:00:00Z